Cures 2.0: Can Congress Recapture The Legislative Magic?
• By Michael McCaughan
Current scrutiny of pricing practices makes the prospect of a “feel good” innovation effort even more appealing to industry – and even harder to advance. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
